Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha-Reference-Cited by-同舟云学术

Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha

Author:

Young Patricia A.¹,Yamada Reiko E.¹,Trinh Kham R.²,Vasuthasawat Alex²,De Oliveira Satiro³,Yamada Douglas H.²,Morrison Sherie L.²,Timmerman John M.¹

Affiliation:

1. Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.

2. Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California.

3. Division of Pediatric Hematology & Oncology, Department of Pediatrics, University of California, Los Angeles, Los Angeles, California.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

Reference36 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. CAR-T cells secreting immune checkpoint antibodies relieve immunosuppression;4TH INTERNATIONAL CONFERENCE ON FRONTIERS OF BIOLOGICAL SCIENCES AND ENGINEERING (FBSE 2021);2022